Dear Editor, The treatment of psoriasis has been revolutionized by biological drugs. Despite their excellent efficacy and safety, their high cost represents a hindrance to a wider and early use
Price variability of TNF-α inhibitor biosimilars among European countries
Geat, Davide;Gisondi, Paolo;Maurelli, Martina;Bellinato, Francesco;Girolomoni, Giampiero
2023-01-01
Abstract
Dear Editor, The treatment of psoriasis has been revolutionized by biological drugs. Despite their excellent efficacy and safety, their high cost represents a hindrance to a wider and early useFile in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Acad Dermatol Venereol - 2023 - Geat - Price variability of TNF‐ inhibitor biosimilars among European countries.pdf
accesso aperto
Tipologia:
Versione dell'editore
Licenza:
Copyright dell'editore
Dimensione
141.97 kB
Formato
Adobe PDF
|
141.97 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.